IRIS
VOGRIG, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.237
NA - Nord America 2.270
EU - Europa 1.250
SA - Sud America 604
AF - Africa 95
OC - Oceania 3
Totale 7.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.184
SG - Singapore 1.752
CN - Cina 512
BR - Brasile 486
IT - Italia 400
HK - Hong Kong 303
VN - Vietnam 267
FR - Francia 142
DE - Germania 139
RU - Federazione Russa 136
FI - Finlandia 91
IN - India 83
KR - Corea 75
IE - Irlanda 72
AR - Argentina 60
GB - Regno Unito 58
NL - Olanda 37
BD - Bangladesh 33
CA - Canada 33
MX - Messico 33
JP - Giappone 32
UA - Ucraina 31
AT - Austria 29
ES - Italia 26
ID - Indonesia 26
TG - Togo 23
TR - Turchia 23
IQ - Iraq 21
SE - Svezia 20
ZA - Sudafrica 18
EC - Ecuador 17
PK - Pakistan 17
SA - Arabia Saudita 14
MA - Marocco 11
PL - Polonia 11
CO - Colombia 10
KZ - Kazakistan 9
TN - Tunisia 9
CL - Cile 8
PT - Portogallo 8
BE - Belgio 7
EG - Egitto 7
LT - Lituania 7
NP - Nepal 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
PY - Paraguay 6
AZ - Azerbaigian 5
JM - Giamaica 5
KE - Kenya 5
KG - Kirghizistan 5
MY - Malesia 5
OM - Oman 5
PE - Perù 5
TH - Thailandia 5
TW - Taiwan 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
PH - Filippine 4
BG - Bulgaria 3
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
JO - Giordania 3
LB - Libano 3
LV - Lettonia 3
RO - Romania 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
CI - Costa d'Avorio 2
CU - Cuba 2
HU - Ungheria 2
IL - Israele 2
MD - Moldavia 2
PS - Palestinian Territory 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
HR - Croazia 1
HT - Haiti 1
IR - Iran 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
Totale 7.447
Salva come PNG Salva come JPEG
Città #
Singapore 585
Ashburn 334
Hong Kong 298
Beijing 229
Fairfield 136
San Jose 115
Boardman 106
Lauterbourg 101
Council Bluffs 93
Ho Chi Minh City 86
Los Angeles 83
Chandler 75
Seoul 75
Hefei 74
Trieste 74
Dublin 72
Helsinki 71
Woodbridge 63
Seattle 60
Houston 58
Dallas 56
Redondo Beach 54
Hanoi 49
Munich 49
São Paulo 47
Wilmington 45
New York 43
Cambridge 41
Milan 39
Buffalo 34
Ogden 29
Frankfurt am Main 27
Nuremberg 27
Belluno 25
The Dalles 24
Venezia 24
Dearborn 23
Lomé 23
Orem 22
Princeton 20
Tokyo 20
Ann Arbor 19
Hyderabad 19
Rome 19
Udine 19
Dong Ket 17
Amsterdam 16
Da Nang 16
Mexico City 16
Santa Clara 16
Tavagnacco 16
London 15
Rio de Janeiro 15
Chicago 14
Lappeenranta 14
Montreal 14
Chennai 13
Jacksonville 13
Redmond 12
Mumbai 11
Poplar 11
Belo Horizonte 9
Biên Hòa 9
Denver 9
Düsseldorf 9
Goiânia 9
Haiphong 9
Vienna 9
Guarulhos 8
Izmir 8
Johannesburg 8
New Delhi 8
Porto Alegre 8
San Diego 8
San Francisco 8
Baghdad 7
Boston 7
Brooklyn 7
Brussels 7
Guayaquil 7
Stockholm 7
Bologna 6
Guangzhou 6
Jakarta 6
Lisbon 6
Norwalk 6
Riyadh 6
Shanghai 6
Shenzhen 6
Sorocaba 6
Toronto 6
Zhengzhou 6
Atlanta 5
Bishkek 5
Cairo 5
Codroipo 5
Curitiba 5
Fayetteville 5
Fortaleza 5
Franca 5
Totale 4.081
Salva come PNG Salva come JPEG
Nome #
Intra-carotid self-injection of alprazolam: an unusual cause of unilateral multiembolic stroke 207
Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis 165
Epidemiology of autoimmune versus infectious encephalitis 158
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features 144
Peculiar EEG signatures, ictal drinking and long-term follow-up in anti-LGI1 encephalitis 137
Epidemiology of paraneoplastic neurological syndromes: a population-based study 134
Effect of thymectomy on refractory autoimmune status epilepticus 133
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario 123
Seizure specificities in patients with antibody-mediated autoimmune encephalitis 120
Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features 110
Back to the future: encephalitis lethargica as an autoimmune disorder? 108
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 105
Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature 102
Sudden unexpected death in epilepsy and ictal asystole in patients with autoimmune encephalitis: a systematic review 98
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors 96
Reply to "Guillain‑Barré syndrome in the COVID‑19 era another occasional cluster?": Insights from two distinct clusters of Guillain–Barré syndrome detected in Europe in the COVID-19 era 96
Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review 93
Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features 89
Central nervous system adverse events of immune checkpoint inhibitors 88
Stroke in patients with SARS-CoV-2 infection: case series 88
Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research 88
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series 87
Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA) 87
Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis 85
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians 84
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes 84
18F-FDG PET brain findings in disease-discordant monozygotic mosaic twins with Cri du Chat (5p-) syndrome 82
Response to Letter to the Editor on the article “Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination” 82
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases 81
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up 80
Movement disorders in oncology: From clinical features to biomarkers 79
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study 79
Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review 78
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and Discrepancies 76
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 76
Application of the anti-IgLON5 disease composite score to assess severity, clinical course, and mortality in a French cohort 75
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis 74
Unclear association between COVID-19 and Guillain-Barré syndrome 74
Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome 72
Bornavirus associated with fatal human encephalitis 72
Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations 71
Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination 70
Central nervous system complications associated with immune checkpoint inhibitors 69
Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment 69
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 68
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration 68
A systematic study of stereotypy in epileptic seizures versus psychogenic seizure-like events 68
Adenovirus COVID-19 Vaccines and Guillain–Barré Syndrome with Facial Paralysis 67
Cranial Nerve Disorders Associated With Immune Checkpoint Inhibitors 66
Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? 65
Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study 65
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes 64
Proceedings of the “International Congress on Structural Epilepsy & Symptomatic Seizures” (STESS, Gothenburg, Sweden, 29–31 March 2023) 64
Reader Response: Prolonged Unconsciousness Following Severe COVID-19 64
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience 64
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota 64
Role of LGI1 protein in synaptic transmission: From physiology to pathology 63
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma 63
Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis 63
Associations between HLA and autoimmune neurological diseases with autoantibodies 62
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition 61
Stroke in patients with COVID-19: Clinical and neuroimaging characteristics 61
Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis 59
Paraneoplastic encephalitis: clinically based approach on diagnosis and management 59
Prevalence and Trajectories of Post-COVID-19 Neurological Manifestations: A Systematic Review and Meta-Analysis 59
Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis 58
Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network 58
Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies 58
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients 58
How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update 57
Neuroimmune disorders in COVID-19 57
Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France 57
Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA B R Antibodies 56
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors 56
Glioblastoma as differential diagnosis of autoimmune encephalitis 55
Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses 55
Nystagmus and lower extremity hyperalgesia after colectomy 55
SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques 54
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies 53
Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis 53
Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity 52
Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis 52
Immunomodulation in the acute phase of autoimmune encephalitis 52
Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes 52
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis 51
Immune Checkpoint Inhibitor-Related Cerebellar Toxicity: Clinical Features and Comparison with Paraneoplastic Cerebellar Ataxia 51
Dramatic response to delayed treatment with tocilizumab in new-onset refractory status epilepticus 51
Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABABR and Anti-Hu Paraneoplastic Neurological Syndromes 51
Predictors and Clinical Characteristics of Relapses in LGI1-Antibody Encephalitis 50
Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis 50
Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors 48
Probable dysimmune epilepsia partialis continua manifesting as epileptic moving toes syndrome: electroclinical features of a challenging case 48
Prognosis of status epilepticus in adults: recent advances and future directions 47
Postencephalitic epilepsy in children and adults: Etiology matters 47
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors. Focus on Chronic Toxicities 47
Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies 45
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review 44
Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study 43
Relapses in Anti-NMDAR Encephalitis: Clinical Characterization and Predictive Features 42
Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma 41
Totale 7.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.265
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 0 0 0 14 25 33
2021/2022183 9 18 37 6 2 0 13 4 3 20 48 23
2022/2023528 20 18 3 19 176 179 4 8 31 6 17 47
2023/2024343 28 22 5 24 40 18 9 31 44 57 29 36
2024/20252.297 85 140 93 70 71 83 110 104 294 240 404 603
2025/20263.824 349 406 415 552 538 302 556 160 274 272 0 0
Totale 7.861